Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 1 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Nicoya Lifesciences Inc. currently has 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 4 actions are being reviewed by 4 distinct examiners, meaning that each case is handled by a different individual. All 4 pending matters are located within 1 distinct art unit, indicating a high degree of technical focus for the company's current patenting activities.
The busiest examiner, AKANBI, ISIAKA O, is responsible for 1 pending case. This matches the overall distribution where 4 distinct examiners handle 4 pending office actions. For a practitioner, this means there is no concentration of cases under a single examiner. Each of the 4 actions must be prosecuted as an independent matter, requiring a unique strategy for each of the 4 distinct examiners involved.
The concentration of 4 pending office actions in 1 distinct art unit allows the practitioner to maintain a consistent technical narrative across the portfolio. However, the involvement of 4 distinct examiners requires separate lines of communication. The fact that the busiest examiner, AKANBI, ISIAKA O, only handles 1 pending case confirms that the current prosecution effort is split evenly between the four assigned examiners, with no single individual overseeing multiple cases in the Biotechnology & Pharmaceuticals area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §102 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AKANBI, ISIAKA O | 1 | 76.6% | +22.8% |
| KIDWELL, KAITLYN ELIZABETH | 1 | 78.0% | +20.0% |
| RAMIREZ, ALEX | 1 | 81.0% | +21.0% |
| FUENTES, DANIELA E | 1 | 4.7% | +10.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19193950 | Digital Microfluidic Systems, Cartridges, and Methods Including Integrated Refractive Index Sensing | KIDWELL, KAITLYN ELIZABETH | — |
| 18579845 | CARTRIDGE, SYSTEM, AND METHOD FOR MOLECULAR DIAGNOSTIC REACTION TESTING | RAMIREZ, ALEX | — |
| 16622761 | PLASMON RESONANCE (PR) SYSTEM AND INSTRUMENT, DIGITAL MICROFLUIDIC (DMF) CARTRIDGE, AND METHODS OF USING LOCALIZED SURFACE PLASMON RESONANCE (LSPR) FOR ANALYSIS OF ANALYTES | FUENTES, DANIELA E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19195680 | Surface Plasmon Resonance Signal Amplification | AKANBI, ISIAKA O | — |
| 19193950 | Digital Microfluidic Systems, Cartridges, and Methods Including Integrated Refractive Index Sensing | KIDWELL, KAITLYN ELIZABETH | — |
| 18579845 | CARTRIDGE, SYSTEM, AND METHOD FOR MOLECULAR DIAGNOSTIC REACTION TESTING | RAMIREZ, ALEX | — |
| 16622761 | PLASMON RESONANCE (PR) SYSTEM AND INSTRUMENT, DIGITAL MICROFLUIDIC (DMF) CARTRIDGE, AND METHODS OF USING LOCALIZED SURFACE PLASMON RESONANCE (LSPR) FOR ANALYSIS OF ANALYTES | FUENTES, DANIELA E | — |
| Art Unit | Apps |
|---|---|
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19195680 | Surface Plasmon Resonance Signal Amplification | AKANBI, ISIAKA O | — | §102 | Non-Final OA | — | Pending | Apr 30, 2025 |
| 19193950 | Digital Microfluidic Systems, Cartridges, and Methods Including Integrated Refractive Index Sensing | KIDWELL, KAITLYN ELIZABETH | — | §103§112Other | Non-Final OA | — | Pending | Apr 29, 2025 |
| 18579845 | CARTRIDGE, SYSTEM, AND METHOD FOR MOLECULAR DIAGNOSTIC REACTION TESTING | RAMIREZ, ALEX | — | §101§103§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 16622761 | PLASMON RESONANCE (PR) SYSTEM AND INSTRUMENT, DIGITAL MICROFLUIDIC (DMF) CARTRIDGE, AND METHODS OF USING LOCALIZED SURFACE PLASMON RESONANCE (LSPR) FOR ANALYSIS OF ANALYTES | FUENTES, DANIELA E | 1677 | §102§103§112 | Non-Final OA | — | Pending | Mar 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial